Literature DB >> 12505278

Fundamentals of prion biology and diseases.

Stephen J DeArmond1, Essia Bouzamondo.   

Abstract

One of the most remarkable changes in medicine during the last 20 years of the 20th century was the shift from the clinical-neuropathological classification of Creutzfeldt-Jakob disease (CJD) and related disorders as 'transmissible spongiform encephalopathies' to a molecular-etiologic classification as 'prion diseases'. We now know that these diseases are caused by abnormalities of the prion protein (PrP). Specifically, CJD is caused by the conversion of the normal, protease-sensitive PrP isoform, designated PrP(C), to a protease resistant isoform, designated PrP(Sc). PrP(Sc) forms into an infectious particle, named a 'prion', that can transmit the disease. Accumulation of PrP(Sc) in the brain causes neurodegeneration. The main goals of this review are to summarize our understanding of the attributes of the PrP molecule that give it the properties of an infectious agent and to describe how different alterations of the PrP molecule cause the multiple known prion disease variants. Finally, the emergence of a new variant of CJD in Great Britain and to a lesser extent in Europe and its relationship to the emergence of a particularly virulent form of bovine spongiform encephalopathy will be discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505278     DOI: 10.1016/s0300-483x(02)00249-4

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  9 in total

1.  Brain-water diffusion coefficients reflect the severity of inherited prion disease.

Authors:  H Hyare; S Wroe; D Siddique; T Webb; N C Fox; J Stevens; J Collinge; T Yousry; J S Thornton
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

2.  Case 8: absentminded and "walking like a drunk".

Authors:  Matthew A Joenig; Justin McArthur
Journal:  MedGenMed       Date:  2005-02-03

3.  The epididymal soluble prion protein forms a high-molecular-mass complex in association with hydrophobic proteins.

Authors:  Heath Ecroyd; Maya Belghazi; Jean-Louis Dacheux; Jean-Luc Gatti
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

Review 4.  Prion protein scrapie and the normal cellular prion protein.

Authors:  Caroline J Atkinson; Kai Zhang; Alan L Munn; Adrian Wiegmans; Ming Q Wei
Journal:  Prion       Date:  2016       Impact factor: 3.931

5.  Persistence of pathogenic prion protein during simulated wastewater treatment processes.

Authors:  Glen T Hinckley; Christopher J Johnson; Kurt H Jacobson; Christian Bartholomay; Katherine D McMahon; Debbie McKenzie; Judd M Aiken; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2008-07-15       Impact factor: 9.028

Review 6.  Variant Creutzfeldt-Jakob disease.

Authors:  Esther A Croes; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

7.  Differential overexpression of SERPINA3 in human prion diseases.

Authors:  S Vanni; F Moda; M Zattoni; E Bistaffa; E De Cecco; M Rossi; G Giaccone; F Tagliavini; S Haïk; J P Deslys; G Zanusso; J W Ironside; I Ferrer; G G Kovacs; G Legname
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

8.  Snord 3A: a molecular marker and modulator of prion disease progression.

Authors:  Eran Cohen; Dana Avrahami; Kati Frid; Tamar Canello; Ephrat Levy Lahad; Sharon Zeligson; Shira Perlberg; Joab Chapman; Oren S Cohen; Esther Kahana; Iris Lavon; Ruth Gabizon
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

Review 9.  Specific genetic modifications of domestic animals by gene targeting and animal cloning.

Authors:  Bin Wang; Jiangfeng Zhou
Journal:  Reprod Biol Endocrinol       Date:  2003-11-13       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.